With the advent of lung cancer screening, and the increasingly frequent use of computed tomography (CT) scanning for investigating non-pulmonary pathology (for example CT coronary angiogram), the number of pulmonary nodules requiring further investigation has risen significantly. Most of these nodules are found in the lung periphery, which presents challenges to biopsy, and many centers rely on trans-thoracic needle biopsy performed under image guidance by radiologists. However, the desire to minimize complications is driving the development of increasingly accurate navigation bronchoscopy platforms, something that will be crucial in the new era of bronchoscopic therapeutics for lung cancer. This review describes these platforms, summarizes the current evidence for their use, and takes a look at future developments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000503329 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robotic bronchoscopy: Evolution of advanced diagnostic technologies for pulmonary lesions.
Best Pract Res Clin Anaesthesiol
March 2024
1400 Holcombe Blvd, FC 13.2000, Houston, TX, 77030, USA. Electronic address:
Lung cancer is among one of the most commonly diagnosed malignancies and is the leading cause of cancer-related mortality in both men and women globally, with an estimated 1.8 million deaths annually. Moreover, it is also the leading cause of cancer related deaths in the United States (U.
View Article and Find Full Text PDFPeripheral pulmonary lesion: novel approaches in endoscopic guidance systems and a state-of-the-art review.
Monaldi Arch Chest Dis
December 2024
Respiratory Disease Unit, Department of Cardiac Thoracic and Vascular Sciences, Ospedale dell'Angelo, Venice.
Diagnosis of peripheral pulmonary lesion (PPL) is the most challenging field in bronchoscopy and interventional pulmonology, which concerns early lung cancer diagnosis. Despite novel techniques and new approaches to the periphery of the lung, almost 25% of PPLs remain undiagnosed. Bronchoscopy with guide systems, virtual and/or electromagnetic navigation, robotic bronchoscopy, and transparenchymal nodule approaches tend to provide a higher percentage of reaching the lesion, but the diagnostic yield rarely exceeds 75%, regardless of the instruments used.
View Article and Find Full Text PDFEstablishment of a Robot-Assisted Bronchoscopy Program at a Veterans Affairs Hospital.
Cureus
November 2024
Pulmonology, Critical Care, Sleep Medicine, and Immunology, Malcom Randall Veteran Affairs Medical Center, Gainesville, USA.
Lung cancer has high mortality rates attributed to late diagnosis and treatment. Robot-assisted bronchoscopy (RAB) offers promising solutions to these challenges, enabling precise navigation and biopsy of small and difficult-to-reach lung nodules. We present the early outcomes and challenges encountered in establishing an RAB program at a Veterans Affairs (VA) Medical Center.
View Article and Find Full Text PDFNovel Strategies for Lung Cancer Interventional Diagnostics.
J Clin Med
November 2024
Department of Medicine, Section of Pulmonary and Critical Care Medicine, Boston University, Boston, MA 02215, USA.
Lung cancer is a major global health issue, with 2.21 million cases and 1.80 million deaths reported in 2020.
View Article and Find Full Text PDFIntraoperative Transbronchial Metallic Coil Marking for Small Peripheral Pulmonary Lesions in a Hybrid Operation Room.
Cancers (Basel)
December 2024
Department of Thoracic and Endocrine Surgery and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School, Kuramoto-cho, Tokushima 770-8503, Japan.
: Computed tomography (CT)-guided transbronchial metallic coil marking is useful for identifying the locations of small peripheral pulmonary lesions. Even deeply located lesions may be accurately identified and resected with adequate margins. This method is also applicable to multiple lesions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!